Axogen Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Axogen has a total shareholder equity of $95.7M and total debt of $49.5M, which brings its debt-to-equity ratio to 51.7%. Its total assets and total liabilities are $188.9M and $93.2M respectively.

Anahtar bilgiler

51.7%

Borç/özkaynak oranı

US$49.51m

Borç

Faiz karşılama oranın/a
NakitUS$21.13m
EşitlikUS$95.69m
Toplam yükümlülüklerUS$93.25m
Toplam varlıklarUS$188.93m

Son finansal sağlık güncellemeleri

Recent updates

Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely

Sep 14
Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely

Would AxoGen (NASDAQ:AXGN) Be Better Off With Less Debt?

Aug 20
Would AxoGen (NASDAQ:AXGN) Be Better Off With Less Debt?

A Piece Of The Puzzle Missing From AxoGen, Inc.'s (NASDAQ:AXGN) 28% Share Price Climb

Jul 29
A Piece Of The Puzzle Missing From AxoGen, Inc.'s (NASDAQ:AXGN) 28% Share Price Climb

Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost

Jun 12
Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost

Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?

Apr 16
Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?

Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump

Mar 28
Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump

Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost

Jan 26
Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost

We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt

Sep 10
We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt

Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues

Aug 09
Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues

AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?

Jan 13
AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?

Is AxoGen (NASDAQ:AXGN) A Risky Investment?

Sep 10
Is AxoGen (NASDAQ:AXGN) A Risky Investment?

AxoGen: Investors Are Positioned Long Leading Into Q2 FY22 Earnings

Aug 02

Axogen estimates Q2 revenue above consensus, reaffirms guidance

Jul 18

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AXGN's short term assets ($82.3M) exceed its short term liabilities ($23.4M).

Uzun Vadeli Yükümlülükler: AXGN's short term assets ($82.3M) exceed its long term liabilities ($69.8M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AXGN's net debt to equity ratio (29.7%) is considered satisfactory.

Borcun Azaltılması: AXGN's debt to equity ratio has increased from 0% to 51.7% over the past 5 years.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: AXGN has sufficient cash runway for more than a year based on its current free cash flow.

Tahmini Nakit Akışı: Insufficient data to determine if AXGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Sağlıklı şirketleri keşfedin